Uncoated biodegradable corrosion resistant bone implants

US10954587B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10954587-B2
Application numberUS-201815933688-A
CountryUS
Kind codeB2
Filing dateMar 23, 2018
Priority dateJun 26, 2012
Publication dateMar 23, 2021
Grant dateMar 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A preferred embodiment is an uncoated, biodegradable corrosion resistant bone implant. The implant includes a body being uncoated and lacking any protective polymer, metallic or ceramic coating, the body being shaped to fix to a bone and/or bone fragment. The body is formed of a magnesium alloy. The magnesium alloy includes from high-purity vacuum distilled magnesium containing impurities, which promote electrochemical potential differences and/or the formation of precipitations and/or intermetallic phases. The impurities are such that the body has a strength of >275 MPa, and a ratio yield point of <0.8, wherein the difference between strength and yield point is >50 MPa.

First claim

Opening claim text (preview).

The invention claimed is: 1. An uncoated, biodegradable corrosion resistant bone implant comprising a body being uncoated and lacking any protective polymer, metallic or ceramic coating, the body being shaped to fix to a bone or bone fragment; the body being a magnesium alloy comprising 0.1 to 1.6% by weight of Zn, 0.001 to 0.5% by weight of Ca, with the rest being high-purity vacuum distilled magnesium containing impurities in a total amount of no more than 0.005% by weight of Fe, Si, Mn, Co, Ni, Cu, Al, Zr and P, wherein the content of Zr impurity is no more than 0.0003% by weight, and wherein the alloy contains elements selected from the group of rare earths with the atomic number 21, 39, 57 to 71 and 89 to 103 in a total amount of no more than 0.002% by weight; wherein a ratio of the content of Zn to the content of Ca is no more than 3, wherein the alloy contains an intermetallic phase of one or both of Ca 2 Mg 6 Zn 3 and Mg 2 Ca in a volume fraction of up to 2% whereby the intermetallic phase has an anti-corrosion effect, and wherein the body has a tensile strength of >275 MPa, and a ratio yield point of <0.8. 2. The bone implant of claim 1 , wherein the body is shaped as a screw, plate, wire or pin. 3. The bone implant of claim 1 , wherein the alloy does not contain an intermetallic phase MgZn. 4. The bone implant of claim 1 , wherein the content of Ca is 0.2 to 0.45% by weight, and the alloy contains the intermetallic phase Mg 2 Ca. 5. The bone implant of claim 1 , wherein a ratio of the content of Zn to the content of Ca is no more than 1. 6. The bone implant of claim 1 , wherein individual impurities contributing to the total sum of the impurities are present in the following amounts in % by weight: Fe ≤0.0005; Si ≤0.0005; Mn ≤0.0005; Co ≤0.0002; Ni ≤0.0002; Cu ≤0.0002; Al ≤0.001; Zr ≤0.0003; P ≤0.0001. 7. The bone implant of claim 1 , wherein a combination of the impurity elements Fe, Si, Mn, Co, Ni, Cu and Al totals no more than 0.004% by weight, the content of Al is no more than 0.001% by weight, and/or the content of Zr is no more than 0.0003% by weight. 8. The bone implant of claim 1 , wherein individual elements from the group of rare earths total no more than 0.001% by weight. 9. The bone implant of claim 1 , wherein the alloy has a fine-grain microstructure with a grain size of no more than 5.0 μm without considerable electrochemical potential differences between the individual matrix phases. 10. The bone implant of claim 1 , wherein the intermetallic phase is as noble as the matrix phase or less noble than the matrix phase. 11. The bone implant of claim 1 , having precipitates with a size of no more than 2.0 μm and are distributed dispersely at the grain boundaries or inside the grain. 12. The bone implant of claim 1 , wherein a combination of the impurity elements Fe, Si, Mn, Co, Ni, Cu and Al totals no more than 0.001% by weight, the content of Al is no more than 0.001% by weight, and/or the content of Zr is no more than 0.0001% by weight. 13. The bone implant of claim 1 , wherein individual elements from the group of rare earths total no more than 0.0003% by weight. 14. The bone implant of claim 1 , wherein individual elements from the group of rare earths total no more than 0.0001% by weight. 15. The bone implant of claim 1 , wherein the alloy has a fine-grain microstructure with a grain size of no more than 3.0 μm without considerable electrochemical potential differences between the individual matrix phases. 16. The bone implant of claim 1 , wherein the alloy has a fine-grain microstructure with a grain size of no more than 1.0 μm. 17. An uncoated, biodegradable corrosion resistant bone implant comprising a body being uncoated and lacking any protective polymer, metallic or ceramic coating, the body being shaped to fix to a bone or bone fragment; the body being a magnesium alloy comprising 0.1 to 1.6% by weight of Zn, 0.001 to 0.5% by weight of Ca, with the rest being high-purity vacuum distilled magnesium containing impurities in a total amount of no more than 0.005% by weight of Fe, Si, Mn, Co, Ni, Cu, Al, Zr and P, wherein the content of Zr impurity is no more than 0.0003% by weight, and wherein the alloy contains elements selected from the group of rare earths with the atomic number 21, 39, 57 to 71 and 89 to 103 in a total amount of no more than 0.002% by weight; wherein a ration of the content of Zn to the content of Ca is no more than 3, wherein the alloy contains an intermetallic phase of one or both of Ca 2 Mg 6 Zn 3 and Mg 2 Ca in a volume fraction of up to 2% whereby the metallic phase has an anti-corrosion effect, and wherein the body has a tensile strength of >300 MPa, a yield point of >225 MPa, and a ratio yield point of <0.75, wherein the difference between tensile strength and yield point is >100 MPa.

Assignees

Inventors

Classifications

  • with zinc or cadmium as the next major constituent · CPC title

  • C22F1/06Primary

    of magnesium or alloys based thereon · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10954587B2 cover?
A preferred embodiment is an uncoated, biodegradable corrosion resistant bone implant. The implant includes a body being uncoated and lacking any protective polymer, metallic or ceramic coating, the body being shaped to fix to a bone and/or bone fragment. The body is formed of a magnesium alloy. The magnesium alloy includes from high-purity vacuum distilled magnesium containing impurities, whic…
Who is the assignee on this patent?
Biotronik Ag
What technology area does this patent fall under?
Primary CPC classification C22F1/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).